Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0348321 (
Haemophilus
)
15,372
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nasopharyngeal carriage of Streptococcus pneumoniae (pneumococcus) plays an important role in the development of invasive diseases, and is also critically involved in setting up respiratory bacterial and viral infections. We previously reported that pneumococcus, one of the commonly carried bacteria in the nasopharynx, regulates non-typeable
Haemophilus
influenzae-induced inflammation by upregulating the expression of Toll-like receptor 2 (TLR2). However, the underlying molecular mechanisms by which TLR2 expression is regulated during pneumococcal infections have not yet been well characterized.
TBX21
is an important transcription factor of adaptive immunity, but there is an increasing body of evidence pointing to a role in regulating innate immunity. The expression of
TBX21
was reported in epithelial cells, but the expression and role of
TBX21
in respiratory epithelium, especially for regulating TLR2, has not yet been studied. In this study, we found that pneumococcus upregulates
TBX21
expression in the respiratory epithelium. The effect of pneumococcus on
TBX21
expression was dependent on its cytoplasmic toxin, pneumolysin. In addition, epithelial
TBX21
expression was not regulated by the gram-negative bacterium non-typeable
Haemophilus
influenzae, peptidoglycan or endotoxin. Deficiency of
TBX21
in mice or knocking down
TBX21
in epithelial cells suppressed pneumococcus-induced TLR2 expression, but not that of TLR4 or TLR9. These results indicate that the adaptive immune regulator
TBX21
participates in regulating innate immune responses, through regulation of TLR2 expression during pneumococcal infections.
...
PMID:TBX21 participates in innate immune response by regulating Toll-like receptor 2 expression in Streptococcus pneumoniae infections. 2490 5